Stay updated with breaking news from Harvard Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Read our preview of key economic and company events in the week ahead, including the ECB's interest rate decision, US CPI for February, and corporate earnings from Greggs, Rivian, and more.
Read our preview of key economic and company events in the week ahead, including the ECB's interest rate decision, US CPI for February, and corporate earnings from Greggs, Rivian, and more.
Analysts expect Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Rating) to post $0.09 earnings per share for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Harvard Bioscience’s earnings. Harvard Bioscience posted earnings per share of $0.08 during the same quarter last year, which indicates a positive year-over-year growth rate of 12.5%. The […]
A liability insurer that abruptly stopped paying defense costs four years into a wrongful death case was in breach of its duty to defend, a Superior Court judge has held. Defendants Biostage and Harvard Bioscience, a pair of biotech companies, were defendants in a lawsuit alleging that a synthetic trachea implant they developed caused a ...
HOLLISTON, Mass., Feb. 21, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended...